- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hinova Pharmaceuticals Inc (688302)
Hinova Pharmaceuticals Inc stock price live, this page displays SS 688302 stock exchange data. View the 688302 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hinova Pharmaceuticals Inc real time stock price chart below.
What Is the Hinova Pharmaceuticals Inc Stock Price Today?
The Hinova Pharmaceuticals Inc stock price today is 66.03.
What Is the Stock Symbol for Hinova Pharmaceuticals Inc?
The stock symbol for Hinova Pharmaceuticals Inc is ""688302.""
What Stock Exchange Does Hinova Pharmaceuticals Inc Trade On?
Hinova Pharmaceuticals Inc is listed and trades on the Shanghai stock exchange.
Is Hinova Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Hinova Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688302 quote. (ISIN: CNE1000059F5)
What Is the Hinova Pharmaceuticals Inc Stock Price Today?
The Hinova Pharmaceuticals Inc stock price today is 66.03.
What Is the Stock Symbol for Hinova Pharmaceuticals Inc?
The stock symbol for Hinova Pharmaceuticals Inc is ""688302.""
What Stock Exchange Does Hinova Pharmaceuticals Inc Trade On?
Hinova Pharmaceuticals Inc is listed and trades on the Shanghai stock exchange.
Is Hinova Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Hinova Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688302 quote. (ISIN: CNE1000059F5)
Shanghai
Currency in CNY
66.03
-0.55(-0.83%)
Closed·
Fair Value
An estimate of a Hinova Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.52
66.74
52 wk Range
23.87
71.98
688302 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688302 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Hinova Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.5266.74
52 wk Range
23.8771.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688302 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hinova Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
58.00
Downside
-12.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Hinova Pharmaceuticals Inc Company Profile
Hinova Pharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes. It develops drugs based on proteolysis targeting chimera and deuteration technology. The company’s products pipeline includes HC-1119, a product in phase III clinical trials with castration resistant prostate cancer indications; HP501, a product in phase II clinical trials for the treatment of hyperuricemia and gout; HP558, a product in phase II clinical trials to treat various late-stage cancers; and HP518, an oral PROTAC drug in phase I clinical trials with a focus on to solve the drug resistance of AR-mutated prostate cancer. Hinova Pharmaceuticals Inc. was founded in 2013 and is headquartered in Chengdu, China.
Compare 688302 to Peers and Sector
Metrics to compare | 688302 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688302PeersSector | |
|---|---|---|---|---|
P/E Ratio | −35.5x | −21.0x | −0.5x | |
PEG Ratio | −1.13 | 0.00 | 0.00 | |
Price/Book | 5.6x | 2.7x | 2.6x | |
Price / LTM Sales | 17,822.7x | 5.1x | 3.3x | |
Upside (Analyst Target) | −12.2% | −3.1% | 40.3% | |
Fair Value Upside | Unlock | −18.5% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 58.00
(-12.16% Downside)
Earnings
Latest Release
Apr 25, 2025
EPS / Forecast
-0.32 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Hinova Pharmaceuticals Trade On?
Hinova Pharmaceuticals is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Hinova Pharmaceuticals?
The stock symbol for Hinova Pharmaceuticals is "688302."
What Is the Hinova Pharmaceuticals Market Cap?
As of today, Hinova Pharmaceuticals market cap is 6.54B.
What Is Hinova Pharmaceuticals's Earnings Per Share (TTM)?
The Hinova Pharmaceuticals EPS (TTM) is -1.85.
From a Technical Analysis Perspective, Is 688302 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Hinova Pharmaceuticals Stock Split?
Hinova Pharmaceuticals has split 0 times.
How Many Employees Does Hinova Pharmaceuticals Have?
Hinova Pharmaceuticals has 174 employees.
What is the current trading status of Hinova Pharmaceuticals (688302)?
As of 16 Aug 2025, Hinova Pharmaceuticals (688302) is trading at a price of 66.03, with a previous close of 66.58. The stock has fluctuated within a day range of 62.52 to 66.74, while its 52-week range spans from 23.87 to 71.98.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.